[EN] 3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE OF A CBL-B INHIBITOR IN COMBINATION WITH A CANCER VACCINE AND/OR ONCOLYTIC VIRUS<br/>[FR] COMPOSÉS DE PIPÉRIDINE SUBSTITUÉS EN POSITION 3 POUR L'INHIBITION DE CBL-B, ET UTILISATION D'UN INHIBITEUR DE CBL-B EN COMBINAISON AVEC UN VACCIN CONTRE LE CANCER ET/OU UN VIRUS ONCOLYTIQUE
申请人:NURIX THERAPEUTICS INC
公开号:WO2020210508A1
公开(公告)日:2020-10-15
Compounds, compositions, and methods for use in inhibiting the E3 enzyme Cbl-b in the ubiquitin proteasome pathway are disclosed. The compounds, compositions, and methods can be used to modulate the immune system, to treat diseases amenable to immune system modulation, and for treatment of cells in vivo, in vitro, or ex vivo. Also disclosed are pharmaceutical compositions comprising a Cbl-b inhibitor and a cancer vaccine, as well as methods for treating cancer using a Cbl-b inhibitor and a cancer vaccine; and pharmaceutical compositions comprising a Cbl-b inhibitor and an oncolytic virus, as well as methods for treating cancer using a Cbl-b inhibitor and an oncolytic virus.